Hemophilia A is a genetic bleeding disorder that can be very dangerous – those affected must take precautions in their daily lives. Yet, there’s hope! Gene therapy offers the potential to cure: https://bit.ly/4976mFY #Hematology #GeneTherapy
Premier Research
生物技术研究
Morrisville，NC 125,624 位关注者
Helping innovators transform life-changing ideas and breakthrough science into new medical treatments.
关于我们
Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. We offer strategic solutions across the entire development lifecycle, from pre-clinical through commercialization, specializing in smart study design and full-service clinical trial management. Leveraging technology and therapeutic expertise, we deliver clean, conclusive data with a focus on reducing development timelines, securing access to the right patients, and effectively navigating global regulations to ensure submission-ready results. As an organization that puts patients first, we pride ourselves on helping customers answer the unmet needs of patients across a broad range of medical conditions. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!
- 网站
-
https://www.premier-research.com
Premier Research的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Morrisville，NC
- 类型
- 私人持股
- 创立
- 1989
- 领域
- Analgesia、CNS/Neuroscience、Rare Disease、Pediatrics、Oncology、Clinical Development Services、Medical Device、Dermatology、Women's Health和Diagnostics
地点
Premier Research员工
动态
-
CAR-T therapy breakthroughs are here! Explore how technology advancements are optimizing manufacturing and trial efficiency for better patient outcomes: https://bit.ly/3Zq6c9E #CARTcelltherapy #Oncology #ClinicalTrials
-
Innovation, insights, impact: Join us at the world’s most comprehensive #hematology event of the year aka ASH 2024! We’ll be at Booth #2500 with experts standing by to connect with you. See you there: https://bit.ly/4erPFGn #ASH24 #ClinicalResearch #DrugDevelopment
-
-
Marketing #medicaldevices and #IVDs in the European single market has changed in recent years. We can help you master the CE marking approval process: https://bit.ly/49dSnhO
-
-
Let’s say you have a ground-breaking dermatology product that could help millions. How do you get FDA clearance? We've outlined how we helped a biotech company do just that – read it here: https://lnkd.in/ew_QkBVh #Innovation #InnovativeTreatments #Dermatology #ClinicalDevelopment #DrugDevelopment
-
Innovation in hematology requires a group of versatile and well-rounded experts. Our team knows this well. Speak with them at ASH 2024! Ashley Herrick, PhD, M. Kenneth Ndugga-Kabuye, MD, FACMG, Radhika 'Sandy' Shah, Leslie Wetherell, and Meera Belur will see you there! Expand your knowledge and network with experts at our Booth #2500:?https://lnkd.in/eS9hgq52 #ASH24 #ASH2024 #HematologyConference #Hematology??
-
Read my new article to understand the benefits of partnering with an experienced Functional Service Provider. Connect with me if you have questions. Premier Research #FSP #ClinicalOutsourcing
-
We know your time is valuable. In case you missed our live CAR-T webinar, we have the recording for you! Plus, you can read the top 5 takeaways here: https://bit.ly/3UZwmgC Have questions? Schedule an in-person meeting with Ashley Herrick, PhD and Meera Belur at ASH in just a couple of weeks: https://bit.ly/4erPFGn #CARTcelltherapy #Oncology #ClinicalTrials
-
-
Engineering CAR-T cells to target solid tumors is not straightforward. Yet, despite the ongoing challenges, progress continues. Learn more about the trends: https://bit.ly/4fRT3eG #CARTcelltherapy
-
-
For pediatric rare disease trials, easing participant burden for the entire family is critical. Explore the benefits of decentralized clinical trials in this patient population: https://bit.ly/4fv8WYI #PediatricRareDisease #PediatricTrials #DecentralizedClinicalTrials
-